Displaying drugs 2026 - 2050 of 2784 in total
Name | Weight | Structure | Description | Categories |
---|---|---|---|---|
Pamidronic acid | 235.0695 C3H11NO7P2 | A bisphosphonate used to treat Paget's disease, to treat hypercalcemia of malignancy, and to treat osteolytic bone lesions. | Antineoplastic Agents / Bisphosphonates / Bone Density Conservation Agents | |
Lidocaine | 234.3373 C14H22N2O | A local anesthetic used in a wide variety of superficial and invasive procedures. | Amides / Analgesics and Anesthetics / Anesthetics for Topical Use | |
Stiripentol | 234.295 C14H18O3 | An antiepileptic agent used in combination with other anticonvulsants to treat seizures associated with Dravet syndrome. | Central Nervous System Depressants | |
Potassium gluconate | 234.245 C6H11KO7 | A potassium supplement indicated in the treatment and prevention of hypokalemia. | Alimentary Tract and Metabolism / Mineral Supplements / Potassium Salt | |
Riluzole | 234.198 C8H5F3N2OS | A glutamate antagonist used to treat amyotrophic lateral sclerosis. | Anticonvulsants / Benzothiazoles / Excitatory Amino Acid Antagonists / Neuroprotective Agents / Thiazoles | |
Lomustine | 233.695 C9H16ClN3O2 | An alkylating agent used as a part of chemotherapeutic regimens for the treatment of primary and metastatic brain tumors as well as refractory or relapsed Hodgkin's disease in addition to surgical and/or radiotherapeutic treatments. | Nitrosoureas | |
Barium sulfate | 233.39 BaO4S | A contrast agent used for CT scans of the gastrointestinal tract. | Barium Sulfate Containing X-Ray Contrast Media | |
Dexmethylphenidate | 233.3062 C14H19NO2 | A norepinephrine-dopamine reuptake inhibitor used in the treatment of ADHD in conjunction with other therapies. | Centrally Acting Sympathomimetics | |
Methylphenidate | 233.3062 C14H19NO2 | A stimulant used in the management of Attention Deficit Hyperactivity Disorder (ADHD). | Centrally Acting Sympathomimetics | |
Sulbactam | 233.242 C8H11NO5S | An beta-lactamase inhibitor antibiotic combined with other antibiotics to treat a variety of susceptible bacterial infections. | beta-Lactamase Inhibitors | |
Melatonin | 232.2783 C13H16N2O2 | An endogenous hormone produced by the pineal gland that regulates sleep-wake cycles and when provided exogenously has beneficial effects on sleep-onset latency; available as an over-the-counter supplement. | Melatonin Receptor Agonists | |
Aminoglutethimide | 232.2783 C13H16N2O2 | An adrenocortical steroid synthesis inhibitor used in the treatment of Cushing's syndrome. | Aromatase Inhibitors | |
Mebutamate | 232.2768 C10H20N2O4 | Mebutamate is a sedative and anxiolytic drug with anti-hypertensive (blood pressure lowering) effects comparable to those of other barbiturates but is only around 1/3rd the potency of secobarbital as a... | Carbamates | |
Kava | 232.275 C14H16O3 | Not Available | Not Available | |
Nalidixic acid | 232.2353 C12H12N2O3 | A quinolone antibiotic used to treat urinary tract infections. | 4-Quinolones / Anti-Bacterial Agents / Naphthyridines / Topoisomerase II Inhibitors | |
Phenobarbital | 232.2353 C12H12N2O3 | A long-lasting barbiturate and anticonvulsant used in the treatment of all types of seizures, except for absent seizures. | Barbiturates and Derivatives | |
Ferumoxytol | 231.531 Fe3O4 | An intravenous iron replacement product used to treat iron deficiency anemia (IDA) in patients with chronic kidney disease (CKD), or in patients who are unable to tolerate or who have not responded adequately to oral iron supplementation. | Ferric Compounds / Ferrous Compounds / Hematinics / Minerals / Paramagnetic Contrast Agent / Parenteral Iron Replacement / Parenteral Nutrition Solutions | |
Aminophenazone | 231.2936 C13H17N3O | An analgesic drug used to treat acute migraine attacks in combination with ergotamine and caffeine. | Pyrazolones | |
Fenfluramine | 231.2573 C12H16F3N | Fenfluramine is a phenethylamine that is structurally similar to serotonin. Due to its ability to increase extracellular serotonin levels, modulate serotonergic and other neurologic receptors, and control neurotransmission, it is effective in treating pharmacoresistant seizures. | Centrally Acting Antiobesity Products | |
Dexfenfluramine | 231.2573 C12H16F3N | For the management of obesity including weight loss and maintenance of weight loss in patients on a reduced calorie diet | Centrally Acting Antiobesity Products | |
Isocarboxazid | 231.2505 C12H13N3O2 | A monoamine oxidase inhibitor used to treat enduring and debilitating symptoms of depression following inadequate clinical response to other antidepressant drugs. | Monoamine Oxidase Inhibitors, Non-Selective | |
Guanabenz | 231.082 C8H8Cl2N4 | An alpha-2 adrenergic agonist used to treat hypertension. | Agents producing tachycardia / Agents that produce hypertension | |
Diazoxide | 230.671 C8H7ClN2O2S | A non diuretic benzothiadiazine indicated for the management of hypoglycemia in patients who produce an excess of insulin caused by a variety of conditions. | Sulfonamides / Thiazide Derivatives | |
Naproxen | 230.2592 C14H14O3 | An NSAID used to treat rheumatoid arthritis, osteoarthritis, ankylosing spondylitis, polyarticular juvenile idiopathic arthritis, tendinitis, bursitis, acute gout, primary dysmenorrhea, and mild to moderate pain. | Antiinflammatory Preparations, Non-Steroids for Topical Use / Antiinflammatory Products for Vaginal Administration / Propionates | |
Clonidine | 230.094 C9H9Cl2N3 | An alpha-2 adrenergic agonist used to treat hypertension and severe cancer pain, among other conditions, and to treat withdrawal symptoms from various substances. It is also used to aid in the diagnosis of pheochromocytoma and to prevent migraines. | Imidazoline Receptor Agonists / Sympathomimetics in Glaucoma Therapy |
Displaying drugs 2026 - 2050 of 2784 in total